GDNF is not required for catecholaminergic neuron survival in vivo

Glial cell line-derived neurotrophic factor (GDNF) has been tested in clinical trials to treat Parkinson’s disease with promising but variable results. Improvement of therapeutic effectiveness requires solid understanding of the physiological role of GDNF in the maintenance of the adult brain catech...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Nat Neurosci
Main Authors: Kopra, Jaakko, Vilenius, Carolina, Grealish, Shane, Härma, Mari-Anne, Varendi, Kärt, Lindholm, Jesse, Castrén, Eero, Võikar, Vootele, Björklund, Anders, Piepponen, T. Petteri, Saarma, Mart, Andressoo, Jaan-Olle
Formato: Artigo
Idioma:Inglês
Publicado: 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4878654/
https://ncbi.nlm.nih.gov/pubmed/25710828
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nn.3941
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares